DNTH · Company research
Dianthus Therapeutics, Inc. Common Stock (DNTH): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (DNTH) Movement as an Input in Quant Signal Sets - Stock Traders Daily | (DNTH) Movement as an Input in Quant Signal Sets Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 16, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics (NASDAQ:DNTH) Earns "Buy" Rating from HC Wainwright - MarketBeat | Dianthus Therapeutics (NASDAQ:DNTH) Earns "Buy" Rating from HC Wainwright MarketBeat | View source ↗ | MarketBeat | Oct 15, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Stock Has Consensus Target Price of $129.83 - MarketBeat | Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Stock Has Consensus Target Price of $129.83 MarketBeat | View source ↗ | MarketBeat | Oct 8, 2026 | neutral | 0 | 0.6 |
| DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results - Stocktwits | DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results Stocktwits | View source ↗ | Stocktwits | Oct 7, 2026 | neutral | 0 | 0.6 |
| Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering? - Yahoo Finance | Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 24, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics (DNTH) Stock Looks Expensive After A 7x Run - Yahoo Finance | Dianthus Therapeutics (DNTH) Stock Looks Expensive After A 7x Run Yahoo Finance | View source ↗ | Yahoo Finance | Sep 23, 2026 | neutral | 0 | 0.6 |
| Dianthus (NASDAQ: DNTH) officer set to sell 20,000 shares - Stock Titan | Dianthus (NASDAQ: DNTH) officer set to sell 20,000 shares Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics: The C1s Shakeout Strengthens The Bull Case - Seeking Alpha | Dianthus Therapeutics: The C1s Shakeout Strengthens The Bull Case Seeking Alpha | View source ↗ | Seeking Alpha | Aug 25, 2026 | neutral | 0 | 0.6 |
| DNTH insider Adam M. Veness plans Rule 144 sale of 16,167 shares - Stock Titan | DNTH insider Adam M. Veness plans Rule 144 sale of 16,167 shares Stock Titan | View source ↗ | Stock Titan | Aug 10, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics Stock Surges After Initiating Major Phase 3 Clinical Trial - TIKR.com | Dianthus Therapeutics Stock Surges After Initiating Major Phase 3 Clinical Trial TIKR.com | View source ↗ | TIKR.com | Jul 20, 2026 | neutral | 0 | 0.6 |
| DNTH Shares Surge 89% Over the Past Six Months: What's Driving It? - Yahoo Finance | DNTH Shares Surge 89% Over the Past Six Months: What's Driving It? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 17, 2026 | neutral | 0 | 0.6 |
| $DNTH stock is down 15% today. Here's what we see in our data. - Quiver Quantitative | $DNTH stock is down 15% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 10, 2026 | neutral | 0 | 0.6 |
| Why is Dianthus Therapeutics stock plunging today? - Investing.com | Why is Dianthus Therapeutics stock plunging today? Investing.com | View source ↗ | Investing.com | Jun 10, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics Inc (DNTH): FDA Makes Trials Easier - Yahoo Finance | Dianthus Therapeutics Inc (DNTH): FDA Makes Trials Easier Yahoo Finance | View source ↗ | Yahoo Finance | Jun 3, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000 - The Motley Fool | Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000 The Motley Fool | View source ↗ | The Motley Fool | Apr 19, 2026 | neutral | 0 | 0.6 |
| Dianthus Therapeutics, Inc. Common Stock (DNTH) Stock Price: Oct 8 Close $82.43 - Gotrade | Dianthus Therapeutics, Inc. Common Stock (DNTH) Stock Price: Oct 8 Close $82.43 Gotrade | View source ↗ | Gotrade | Feb 2, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.